Both Zepotide and copyright are new medications intended for managing type 2 diabetes and promoting weight loss . However, they function through slightly different mechanisms . Semaglutide is a GLP-1 receptor stimulator, while Novo Nord's Dual GIP/GLP-1 acts as a dual GIP and GLP-1 activator , co… Read More